Publications all publications 2021 Excellent Response With Alpelisib and Bicalutamide for Advanced Salivary Duct Carcinoma With PIK3CA Mutation and High Androgen Receptor Expression-A Case Report View publication (pdf) 2021 Development and validation of a multigene variant profiling assay to guide targeted and immuno therapy selection in solid tumors View publication (pdf) 2021 Improved Treatment Outcomes by Using Patient Specific Drug Combinations in Mammalian Target of Rapamycin Activated Advanced Metastatic Cancers View publication (pdf) 2021 Angiogenesis Inhibitors in Personalized Combination Regimens for the Treatment of Advanced Refractory Cancers View publication (pdf) 2020 Evaluation of Circulating Tumor Cell Clusters for Pan-Cancer Noninvasive Diagnostic Triaging View publication (pdf) 2020 A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancer View publication (pdf) 2020 Clinical utility of circulating tumor‑associated cells to predict and monitor chemo‑response in solid tumors View publication (pdf) 2020 Long Overall Survival in a Case of Refractory Stage IV Squamous Cell Carcinoma of Lung Treated with Personalized De Novo Combination Regimen View publication (pdf) 2020 Hallmark Circulating Tumor-Associated Cell Clusters Signify 230 Times Higher One-Year Cancer Risk View publication (pdf) 2019 Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers: results from the RESILIENT trial View publication (pdf) 2019 Adaptive, Iterative, Long-Term Personalized Therapy Management in a Case of Stage IV Refractory NSCLC View publication (pdf) 2019 Circulating ensembles of tumor-associated cells: A redoubtable new systemic hallmark of cancer View publication (pdf)
